Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23516391 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Study of GSK1363089 in Metastatic Gastric Cancer
Condition: Neoplasms, Gastrointestinal Tract
Intervention: Drug: GSK1363089 (formerly XL880)

Indicates status has not been verified in more than two years